Results 151 to 160 of about 3,568 (202)

Dermatologic Adverse Events in Patients Receiving Duvelisib Single-Agent and Combination Therapies. [PDF]

open access: yesClin Lymphoma Myeloma Leuk
Liao V   +5 more
europepmc   +1 more source

Sun protection behaviour checklist for targeted counselling in skin cancer patients. [PDF]

open access: yesAustralas J Dermatol, 2022
Cowen EA   +7 more
europepmc   +1 more source

Clinical Significance Unveiled: Understanding the Meaning of FACE-Q Skin Cancer Scores for Improved Patient Care. [PDF]

open access: yesPsychooncology
Veldhuizen IJ   +17 more
europepmc   +1 more source

Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab. [PDF]

open access: yesLeuk Lymphoma, 2023
Parisi R   +7 more
europepmc   +1 more source

Differentiating seborrheic keratosis from melanoma among lesions exhibiting blue-white veil: A retrospective study. [PDF]

open access: yesJ Am Acad Dermatol
Dana IN   +11 more
europepmc   +1 more source

Nanohardness of grains and grain boundaries in reactive sintered (Ti-Zr-Nb-Hf-Ta)B2 + (Ti-Zr-Nb-Hf-Ta)C composite

open access: yesJournal of the European Ceramic Society
A. Naughton-Duszová   +8 more
semanticscholar   +1 more source

Translational Potential of Fluorescent PARP1 Inhibitor as a Molecular Contrast Agent for Diagnosis of Basal Cell Carcinoma. [PDF]

open access: yesJ Nucl Med
Ricanati M   +11 more
europepmc   +1 more source

Struktura substancjalna osoby ludzkiej

open access: yesCollectanea Theologica, 2019
Piotr Liszka
doaj   +1 more source

Use of Dupilumab to Manage Antibody-Drug Conjugate-Induced Cutaneous Toxicities.

open access: yesJAMA Dermatol
Nykaza I   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy